<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Cholesteatoma in children
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Cholesteatoma in children
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Cholesteatoma in children
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Glenn C Isaacson, MD, FAAP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anna H Messner, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 23, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         A cholesteatoma (sometimes called a keratoma) is an abnormal growth of squamous epithelium in the middle ear and mastoid. It may progressively enlarge to surround and destroy the ossicles, resulting in conductive hearing loss. Hearing loss also may occur if the cholesteatoma obstructs the Eustachian tube orifice, leading to middle ear effusion. Early diagnosis is crucial to an optimal outcome.
        </p>
        <p>
         The clinical features and treatment of cholesteatomas in children will be reviewed here. Other complications of otitis media are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">
          "Acute otitis media in children: Epidemiology, microbiology, and complications", section on 'Complications and sequelae'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          TERMINOLOGY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cholesteatoma
         </strong>
         – A cholesteatoma is an abnormal accumulation of squamous epithelium within the middle ear and mastoid [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital cholesteatoma
         </strong>
         – The classic definition of a congenital cholesteatoma is a cholesteatoma that develops behind an intact tympanic membrane (TM) in a child with no history of middle ear disease  (
         <a class="graphic graphic_picture graphicRef72870" href="/z/d/graphic/72870.html" rel="external">
          picture 1A
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ]. However, since most children have some history of middle ear disease during infancy, cholesteatomas are considered to be congenital if they occur in children who have an intact TM and no history of ear surgery [
         <a href="#rid4">
          4-6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acquired cholesteatoma
         </strong>
         – Acquired cholesteatomas develop after birth, usually as a complication of chronic middle ear disease.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The true incidence of cholesteatoma is not known. Retrospective data suggest a mean annual incidence of 9.2 cases per 100,000 persons of all ages (range 3.7 to 13.9) [
         <a href="#rid7">
          7
         </a>
         ]. In studies limited to children, the incidence ranges from approximately 5 to 15 per 100,000 children [
         <a href="#rid2">
          2
         </a>
         ]. Cholesteatomas are bilateral in approximately 4 percent of cases [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital cholesteatoma
         </strong>
         – Congenital cholesteatomas account for 1 to 5 percent of cholesteatomas in most published series [
         <a href="#rid9">
          9
         </a>
         ]. In a series of 172 cases of congenital cholesteatoma, the average age at diagnosis was five years [
         <a href="#rid6">
          6
         </a>
         ]. Nearly three-quarters of cases occurred in boys. Most cases involved ≥2 quadrants. In cases that confined to one quadrant, 82 percent involved anterosuperior quadrant  (
         <a class="graphic graphic_figure graphicRef57110" href="/z/d/graphic/57110.html" rel="external">
          figure 1
         </a>
         ). The ossicular chain and mastoid were involved in 43 percent and 23 percent of cases, respectively.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acquired cholesteatoma
         </strong>
         – Most cases of cholesteatoma are acquired. The posterosuperior quadrant is the most common location  (
         <a class="graphic graphic_figure graphicRef57110" href="/z/d/graphic/57110.html" rel="external">
          figure 1
         </a>
         ). In a retrospective study of &gt;45,000 children who had undergone tympanostomy tube placement, 1 percent developed cholesteatoma [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Predisposing factors –
         </strong>
         Predisposing factors for acquired cholesteatoma include [
         <a href="#rid1">
          1,7,10
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         History of recurrent acute otitis media and/or chronic middle ear effusions
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Older age at first placement of tympanostomy tubes, and increasing number of, and longer interval between, insertions [
         <a href="#rid10">
          10
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cleft palate [
         <a href="#rid11">
          11-13
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Craniofacial anomalies
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Turner syndrome [
         <a href="#rid14">
          14
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Down syndrome [
         <a href="#rid15">
          15
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Family history of chronic middle ear disease and/or cholesteatoma [
         <a href="#rid16">
          16-18
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          PATHOGENESIS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital
         </strong>
         – The origin of the squamous epithelium in congenital cholesteatomas is a matter of debate [
         <a href="#rid9">
          9,19,20
         </a>
         ]. The most widely held theory suggests that fetal epithelial rests in the middle ear persist after birth and evolve into squamous inclusion cysts (congenital cholesteatomas) behind an intact tympanic membrane (TM) [
         <a href="#rid21">
          21
         </a>
         ]. This theory is supported by the histologic demonstration of single or multiple epidermoid formations in fetal temporal bones that typically disappear before birth [
         <a href="#rid22">
          22
         </a>
         ]. Alternative theories suggest that the middle ear is seeded by squamous cells in the amniotic fluid or from bits of the outer surface of the TM following infection or microperforation [
         <a href="#rid23">
          23-25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acquired
         </strong>
         – Acquired cholesteatomas usually arise from focal retractions of the TM. Less commonly, they can develop as a consequence of squamous epithelium entering the middle ear.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Retraction pocket
         </strong>
         – Retraction pockets are invaginations of the TM that form in patients with chronic Eustachian tube dysfunction, negative middle ear pressure, and focal collapse of the TM [
         <a href="#rid19">
          19,20
         </a>
         ]. As the retraction pocket is progressively pulled into the middle ear space, it forms a large pouch with a narrow neck. The pouch traps desquamating cells, forming a cholesteatoma lined by the metabolically active epithelium of the TM and filled with dead keratin debris  (
         <a class="graphic graphic_figure graphicRef56231" href="/z/d/graphic/56231.html" rel="external">
          figure 2
         </a>
         ). The metabolically active squamous epithelium has the ability to erode bone: first, the delicate ossicles  (
         <a class="graphic graphic_picture graphicRef75737" href="/z/d/graphic/75737.html" rel="external">
          picture 2
         </a>
         ) and then the solid cortices of the temporal bone. The keratin debris may become infected following water exposure or a middle ear infection, resulting in chronic purulent drainage  (
         <a class="graphic graphic_picture graphicRef76079" href="/z/d/graphic/76079.html" rel="external">
          picture 1C
         </a>
         ). (See
         <a class="local">
          'Natural history and complications'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Areas of predilection for retraction pockets include old tympanostomy tube sites, the posterosuperior portion of the TM overlying the entrance to the mastoid, and the pars flaccida at the top of the TM  (
         <a class="graphic graphic_figure graphicRef64096" href="/z/d/graphic/64096.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid26">
          26
         </a>
         ]. Structural variations in the fibrous layer of the TM may account for weakness in these areas [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other mechanisms
         </strong>
         – Less common mechanisms by which squamous epithelium may enter the middle ear include [
         <a href="#rid19">
          19
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Through a perforation at the outer edge of the TM (secondary acquired cholesteatoma)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Through a temporal bone fracture  (
         <a class="graphic graphic_picture graphicRef53944" href="/z/d/graphic/53944.html" rel="external">
          picture 3
         </a>
         )
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         As a rare complication of myringotomy (with or without tympanostomy tube placement)  (
         <a class="graphic graphic_picture graphicRef79099" href="/z/d/graphic/79099.html" rel="external">
          picture 4
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6305.html" rel="external">
          "Overview of tympanostomy tube placement, postoperative care, and complications in children", section on 'Cholesteatoma'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          CLINICAL FEATURES
         </span>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cholesteatomas may be asymptomatic or may present with symptoms attributable to the cholesteatoma (otorrhea, hearing loss) [
         <a href="#rid1">
          1,28
         </a>
         ]. Most affected children have a history of recurrent acute otitis media and/or chronic middle ear effusions.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Asymptomatic children
         </strong>
         – In children without symptoms, the lesion may be detected on routine physical examination based upon the following characteristic otoscopic findings (see
         <a class="local">
          'Otoscopic examination'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A white mass behind an intact TM  (
         <a class="graphic graphic_picture graphicRef72870 graphicRef59937 graphicRef76079" href="/z/d/graphic/72870.html" rel="external">
          picture 1A-C
         </a>
         ), which is the most common presentation for congenital cholesteatomas [
         <a href="#rid6">
          6,29
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A deep retraction pocket with or without granulation and skin debris  (
         <a class="graphic graphic_picture graphicRef54514" href="/z/d/graphic/54514.html" rel="external">
          picture 5
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Focal granulation on the surface of the TM, especially at the periphery  (
         <a class="graphic graphic_picture graphicRef72182" href="/z/d/graphic/72182.html" rel="external">
          picture 6
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Symptomatic children
         </strong>
         – Chronic ear drainage is the most common presenting symptom for acquired cholesteatomas [
         <a href="#rid29">
          29
         </a>
         ]. Children who develop cholesteatoma as a complication of prior surgery may present with new onset hearing loss in the affected ear. Children rarely complain of hearing loss, particularly if it is unilateral [
         <a href="#rid2">
          2
         </a>
         ]. Thus, it is important to test hearing periodically in children with a history of recurrent or persistent middle ear disease. Rarely, children with cholesteatoma may present with a late complication (eg, facial nerve palsy). (See
         <a class="local">
          'Natural history and complications'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3119774919">
         <span class="h2">
          Otoscopic findings
         </span>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Congenital cholesteatomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital cholesteatomas can occur anywhere in the temporal bone but have a predilection for the anterosuperior quadrant of the middle ear, just above the Eustachian tube opening  (
         <a class="graphic graphic_picture graphicRef72870" href="/z/d/graphic/72870.html" rel="external">
          picture 1A
         </a>
         ) [
         <a href="#rid6">
          6,30
         </a>
         ]. Congenital cholesteatomas in this location may obstruct the Eustachian tube opening early in the course, resulting in middle ear effusion, which can complicate the diagnosis [
         <a href="#rid6">
          6,31
         </a>
         ]. Congenital cholesteatomas also occur in the posterosuperior quadrant  (
         <a class="graphic graphic_picture graphicRef70826" href="/z/d/graphic/70826.html" rel="external">
          picture 7
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         In the early stages, a congenital cholesteatoma may appear as a subtle whitish discoloration or spherical, white cyst behind an otherwise normal-appearing TM  (
         <a class="graphic graphic_picture graphicRef59937" href="/z/d/graphic/59937.html" rel="external">
          picture 1B
         </a>
         ). As the lesion grows, it makes contact with the underside of the TM and becomes more obvious. With further expansion, the cholesteatoma can replace the middle ear space. The normal variegated appearance of the middle ear space is replaced by a bulging, white mass, which displaces the TM outwardly  (
         <a class="graphic graphic_picture graphicRef50092" href="/z/d/graphic/50092.html" rel="external">
          picture 8
         </a>
         ). Perforation of the TM and chronic ear drainage are late findings. They usually follow the onset of hearing loss by months or years [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         The mean age of diagnosis is four to five years [
         <a href="#rid5">
          5,6,32
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Acquired cholesteatomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical features suggestive of acquired cholesteatomas include deep retraction pockets  (
         <a class="graphic graphic_picture graphicRef54514" href="/z/d/graphic/54514.html" rel="external">
          picture 5
         </a>
         ), a white mass behind the TM  (
         <a class="graphic graphic_picture graphicRef76079" href="/z/d/graphic/76079.html" rel="external">
          picture 1C
         </a>
         ), focal granulation at the periphery of the TM  (
         <a class="graphic graphic_picture graphicRef72182" href="/z/d/graphic/72182.html" rel="external">
          picture 6
         </a>
         ), new-onset hearing loss, and ear drainage for more than two weeks despite treatment.
        </p>
        <p>
         Retraction pockets are recognized by careful examination of the TM. They are said to be "shallow" when the full extent of the pocket is visible by otoscopy  (
         <a class="graphic graphic_picture graphicRef82650" href="/z/d/graphic/82650.html" rel="external">
          picture 9
         </a>
         ). They are "deep" when they disappear into the crevices of the middle ear or into the mastoid air spaces  (
         <a class="graphic graphic_picture graphicRef54514" href="/z/d/graphic/54514.html" rel="external">
          picture 5
         </a>
         ).
        </p>
        <p>
         Deep pockets can collect debris that cannot be seen with otoscopy [
         <a href="#rid33">
          33
         </a>
         ]. They are assumed to be cholesteatomas until proven otherwise. If a retraction pocket expands into the middle ear, its mouth may be visible near the edge of the TM. The cholesteatoma sac, filled with dead keratin debris, may appear as a white mass behind the TM  (
         <a class="graphic graphic_picture graphicRef76079" href="/z/d/graphic/76079.html" rel="external">
          picture 1C
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H3978239427">
         <span class="h1">
          NATURAL HISTORY AND COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cholesteatomas that are not surgically excised continue to enlarge and may become secondarily infected.
        </p>
        <p>
         Complications of cholesteatoma include hearing loss, cranial nerve palsies (facial [seventh cranial nerve], abducens [sixth cranial nerve]), other neurologic signs and symptoms (eg, vertigo), venous thrombosis, and potentially life-threatening infections (eg, brain abscess, meningitis) [
         <a href="#rid4">
          4,34-39
         </a>
         ].
        </p>
        <p>
         Congenital cholesteatoma may grow for years without causing symptoms, which highlights the importance of careful examination of the middle ear during routine health care maintenance [
         <a href="#rid6">
          6,40
         </a>
         ]. In a review of 172 cases of congenital cholesteatoma from a single institution, the average age at diagnosis was five years. The ossicular chain was involved in 43 percent and the mastoid in 23 percent [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         In the late stages, cholesteatoma (congenital or acquired) can destroy intratemporal structures, causing sensorineural deafness or paralysis of the facial nerve. It can erode through the walls of the mastoid, compressing the temporal lobe of the brain or presenting as a subcutaneous mass  (
         <a class="graphic graphic_diagnosticimage graphicRef56423" href="/z/d/graphic/56423.html" rel="external">
          image 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6217.html" rel="external">
          "Facial nerve palsy in children"
         </a>
         .)
        </p>
        <p>
         Advanced cholesteatomas may become secondarily infected [
         <a href="#rid41">
          41
         </a>
         ]. The organisms most commonly cultured from infected cholesteatomas include
         <em>
          Pseudomonas aeruginosa
         </em>
         ,
         <em>
          Proteus
         </em>
         species,
         <em>
          Bacteroides
         </em>
         , and
         <em>
          Peptococcus
         </em>
         /
         <em>
          Peptostreptococcus
         </em>
         [
         <a href="#rid2">
          2
         </a>
         ]. Chronic bacterial infection may result in retrograde thrombosis of the cerebral veins, leading to formation of epidural abscess, a surgical emergency [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H1108390004">
         <span class="h2">
          Clinical suspicion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cholesteatoma should be suspected in children with any of the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Characteristic otoscopic findings on examination (see
         <a class="local">
          'Otoscopic findings'
         </a>
         above and
         <a class="local">
          'Otoscopic examination'
         </a>
         below)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         New-onset hearing loss in a previously operated ear
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An ear with persistent otorrhea for more &gt;2 weeks despite appropriate treatment
        </p>
        <p>
        </p>
        <p>
         Children with these findings should be referred to an otolaryngologist for confirmation of the diagnosis and definitive management. (See
         <a class="local">
          'Diagnosis'
         </a>
         below and
         <a class="local">
          'Surgical treatment'
         </a>
         below.)
        </p>
        <p>
         Early detection of cholesteatoma requires careful otoscopic examination at routine health maintenance visits [
         <a href="#rid1">
          1,43
         </a>
         ]. Early detection may avoid hearing loss and the need for extensive surgery [
         <a href="#rid4">
          4,34
         </a>
         ]. Early lesions are best detected by inspecting the outer edges of the tympanic membrane (TM).
        </p>
        <p class="headingAnchor" id="H1010649499">
         <span class="h2">
          Otoscopic examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Characteristic otoscopic findings of cholesteatoma include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A white mass behind an intact TM  (
         <a class="graphic graphic_picture graphicRef72870" href="/z/d/graphic/72870.html" rel="external">
          picture 1A
         </a>
         and
         <a class="graphic graphic_picture graphicRef59937" href="/z/d/graphic/59937.html" rel="external">
          picture 1B
         </a>
         and
         <a class="graphic graphic_picture graphicRef76079" href="/z/d/graphic/76079.html" rel="external">
          picture 1C
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A deep retraction pocket  (
         <a class="graphic graphic_picture graphicRef54514" href="/z/d/graphic/54514.html" rel="external">
          picture 5
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Focal granulation on the surface of the TM especially at the periphery  (
         <a class="graphic graphic_picture graphicRef72182" href="/z/d/graphic/72182.html" rel="external">
          picture 6
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Particular attention should be paid to the posterosuperior quadrant and anterosuperior quadrant  (
         <a class="graphic graphic_figure graphicRef57110" href="/z/d/graphic/57110.html" rel="external">
          figure 1
         </a>
         ), which are the most frequent locations of acquired and congenital cholesteatomas, respectively. (See
         <a class="local">
          'Acquired cholesteatomas'
         </a>
         above and
         <a class="local">
          'Congenital cholesteatomas'
         </a>
         above.)
        </p>
        <p>
         To ensure an optimal examination, the otoscope's light source must have adequate brightness and cerumen removal may be necessary to expose the entire TM. (See
         <a class="medical medical_review" href="/z/d/html/6841.html" rel="external">
          "Cerumen", section on 'Cerumen removal'
         </a>
         .)
        </p>
        <p>
         Otoscopy may be difficult if there is middle ear fluid or if the child is not cooperative [
         <a href="#rid2">
          2
         </a>
         ]. In such cases, if cholesteatoma is suspected, referral to otolaryngology for examination with an operating microscope may be necessary [
         <a href="#rid2">
          2
         </a>
         ]. Computed tomography (CT) of the temporal bone is another option but is less helpful if there is fluid in the middle ear since middle ear fluid and cholesteatoma have the same appearance on CT. (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1440419170">
         <span class="h2">
          Hearing evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with suspected cholesteatoma should undergo audiometric testing to detect associated hearing loss. Cholesteatoma usually is associated with some degree of conductive hearing loss (maximum threshold of 50 decibels), although hearing may be normal if the ossicular chain is not involved [
         <a href="#rid29">
          29
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2114790007">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of cholesteatoma is confirmed by the otolaryngologist using visual examination under an operating microscope, high-resolution computed tomography (CT), diffusion-weighted magnetic resonance imaging (DW-MRI), and/or surgical exploration [
         <a href="#rid28">
          28,44-46
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Examination (with or without tympanostomy tube [TT] placement)
         </strong>
         – Visual examination and palpation of the TM under an operating microscope is often diagnostic. When an effusion is present, some surgeons prefer to place a TT during the initial examination under anesthesia as a preliminary step before proceeding with temporal bone CT and surgery [
         <a href="#rid29">
          29,47
         </a>
         ]. TT placement enhances the value of CT by introducing air into the middle ear and mastoid (CT does not permit differentiation between fluid and the soft tissue density of the cholesteatoma). Preliminary TT placement also improves the chance of finding a dry, uninflamed middle ear at the time of cholesteatoma removal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Temporal bone CT
         </strong>
         – The evaluation usually includes high-resolution CT of the temporal bone to confirm the nature and extent of the lesion  (
         <a class="graphic graphic_diagnosticimage graphicRef56423" href="/z/d/graphic/56423.html" rel="external">
          image 1
         </a>
         ) and presence of complications. However, an experienced otolaryngologist may sometimes remove a small congenital cholesteatoma without performing CT.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          DW-MRI
         </strong>
         – DW-MRI can be helpful in the diagnosis of cholesteatoma since it can differentiate between cholesteatoma, middle ear fluid, and granulation tissue; however, it may not identify small volumes of cholesteatoma [
         <a href="#rid48">
          48
         </a>
         ]. DW-MRI has been shown to be both sensitive and specific for detecting cholesteatoma in the temporal bone. Non-echo planar DW-MRI is better for detecting smaller lesions. DW-MRI can provide information on anatomic areas not easily seen on otoscopy and can assist with surveillance for recurrence after primary cholesteatoma surgery [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1910588879">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of cholesteatoma includes other white lesions of the tympanic membrane (TM). The following lesions may be easily confused with cholesteatomas  (
         <a class="graphic graphic_picture graphicRef62245" href="/z/d/graphic/62245.html" rel="external">
          picture 10
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myringosclerosis appears as whitish plaques of calcium and phosphate crystals  (
         <a class="graphic graphic_picture graphicRef58460" href="/z/d/graphic/58460.html" rel="external">
          picture 11
         </a>
         ). These plaques are firm on palpation, contained within the middle layer of the TM, typically crescent-shaped, and move with the TM during pneumatic otoscopy [
         <a href="#rid29">
          29
         </a>
         ]. In contrast, cholesteatomas are soft, occupy the middle ear space, and do not move with the TM during pneumatic otoscopy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         White foreign bodies  (
         <a class="graphic graphic_picture graphicRef73085" href="/z/d/graphic/73085.html" rel="external">
          picture 12
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exostoses, which are outgrowths of bone into the external ear canal  (
         <a class="graphic graphic_picture graphicRef53371" href="/z/d/graphic/53371.html" rel="external">
          picture 13
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prosthetic and graft material in operated ears.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inclusion cysts of TM  (
         <a class="graphic graphic_picture graphicRef54229" href="/z/d/graphic/54229.html" rel="external">
          picture 14
         </a>
         ). These lesions occupy the middle layers of the TM but do not extend into the middle ear. Similar to myringosclerosis lesions but unlike cholesteatomas, inclusion cysts of the TM move with the TM during pneumatic otoscopy [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Occasionally, a bulging acute otitis media may be hard to differentiate from a large congenital cholesteatoma  (
         <a class="graphic graphic_picture graphicRef76431" href="/z/d/graphic/76431.html" rel="external">
          picture 15
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         The history may be helpful in differentiating cholesteatoma from some of these lesions (eg, foreign body, prosthetic, and graft material). Otomicroscopy with palpation or computed tomography (CT) may be necessary to differentiate these disorders.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          SURGICAL TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goals of surgical treatment are eradication of the keratinizing squamous epithelium from the temporal bone and preservation or restoration of hearing [
         <a href="#rid50">
          50
         </a>
         ]. The extent and effectiveness of surgery depends upon the size and stage of the cholesteatoma [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Early cholesteatoma
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital
         </strong>
         – Small, congenital cholesteatomas are usually treated by middle ear exploration and simple excision. Access to the tympanic membrane (TM) is either through the ear canal or via a postauricular incision, reflecting the pinna out of the way for better exposure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The TM is reflected downward after incision of the ear canal skin  (
         <a class="graphic graphic_figure graphicRef58365" href="/z/d/graphic/58365.html" rel="external">
          figure 4
         </a>
         ) and elevation of the top one-half of the tympanic annulus. Usually, the TM is left attached to the end of the malleus (umbo). The cyst is detached from its mucosal connections and delivered intact. The TM is returned to its normal anatomic position.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Excision of congenital cholesteatomas through a more limited exposure is possible using the newer generation of small endoscopes [
         <a href="#rid52">
          52
         </a>
         ]. Endoscopically assisted transcanal surgery without a postauricular incision is often possible, even in young children with small external ear canals  (
         <a class="graphic graphic_picture graphicRef117715" href="/z/d/graphic/117715.html" rel="external">
          picture 16
         </a>
         ) [
         <a href="#rid53">
          53,54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Retraction pocket
         </strong>
         – Early retraction pocket cholesteatomas may be successfully treated with middle ear ventilation and mechanical reduction of the retraction pocket [
         <a href="#rid47">
          47,55-57
         </a>
         ]. Tympanostomy tube placement (with or without adenoidectomy) releases the vacuum that retracts the TM. Once the middle ear is ventilated, it is often possible to mechanically reduce the pocket by removing debris and sucking the pocket out with a small Frazier ear suction  (
         <a class="graphic graphic_picture graphicRef54514" href="/z/d/graphic/54514.html" rel="external">
          picture 5
         </a>
         ). The stretched segment of TM will return to its normal appearance, though it remains thin and will appear hypermobile on pneumatic otoscopy. It may retract again once the tube extrudes, so follow-up is important [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6305.html" rel="external">
          "Overview of tympanostomy tube placement, postoperative care, and complications in children", section on 'Postoperative care'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Retraction pockets that cannot be reduced require excision and grafting of the TM. For lesions limited to the middle ear, exploration of the middle ear and microdissection of the cholesteatoma sac (matrix) is usually sufficient. Endoscopes allow access to recesses of the middle ear not normally visible with microscopy [
         <a href="#rid58">
          58
         </a>
         ]. With endoscopic or endoscopically assisted techniques, it may be possible to preserve involved ossicles and avoid mastoidectomy in some cases without compromising long-term control of disease  (
         <a class="graphic graphic_picture graphicRef117714" href="/z/d/graphic/117714.html" rel="external">
          picture 17
         </a>
         ) [
         <a href="#rid59">
          59,60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Because the cholesteatoma sac is a retracted portion of the TM, its removal produces a hole that must be repaired, usually with the thin, strong fascia overlying the temporalis muscle or with cartilage from the pinna or tragus. Tympanostomy tube placement (with or without adenoidectomy) at the time of grafting or at the first sign of retraction may prevent recurrent cholesteatoma formation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the ossicles have been damaged by the osteolytic effects of the cholesteatoma or if it was necessary to remove a portion of the ossicles to fully expose the cholesteatoma, the ossicular chain is reconstructed using bone, cartilage, or prosthetic material. Hearing results are generally good if the stapes superstructure can be spared. Conductive hearing losses usually result if only the footplate of the stapes is left [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Advanced cholesteatoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         When a cholesteatoma (congenital or acquired) has extended beyond the accessible confines of the middle ear, middle ear exploration is usually inadequate to permit complete removal. To reach the temporal bone spaces above and behind the middle ear, it is necessary to remove the overlying plates of cranial bone  (
         <a class="graphic graphic_figure graphicRef71262" href="/z/d/graphic/71262.html" rel="external">
          figure 5
         </a>
         ).
        </p>
        <p>
         The pneumatized space just superior to the middle ear is called the epitympanum or attic. The attic contains the head of the malleus and the body of the incus. When cholesteatoma enters the attic, it often encircles the ossicular heads and cannot be freed, even when visualized with a microscope or angled endoscope. In such cases, the overlying bone, called the scutum, must be drilled away for access  (
         <a class="graphic graphic_figure graphicRef71262" href="/z/d/graphic/71262.html" rel="external">
          figure 5
         </a>
         ) [
         <a href="#rid62">
          62
         </a>
         ]. The defect created by atticotomy is often reconstructed with cartilage from the pinna to prevent postoperative retraction of the TM.
        </p>
        <p class="headingAnchor" id="H2201354954">
         <span class="h2">
          Mastoid involvement
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cholesteatoma involving the mastoid is treated by mastoidectomy (the surgical removal of the mastoid cortical bone and underlying air cells to gain access to the cholesteatoma). There are several variations in surgical approach, but mastoidectomies generally are of two types, canal wall-up and canal wall-down mastoidectomy (the "canal" part of these terms refers to the posterior portion of the external auditory canal that separates the canal from the mastoid air cells):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Canal wall-up surgery
         </strong>
         – Canal wall-up surgeries include complete, simple, or cortical mastoidectomy. These are closed-cavity procedures. The posterior portion of the external auditory canal is preserved. In such cases, the healed ear usually looks normal when examined with an otoscope  (
         <a class="graphic graphic_figure graphicRef58420" href="/z/d/graphic/58420.html" rel="external">
          figure 6
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Canal wall-down surgery
         </strong>
         – Canal wall-down surgeries include radical mastoidectomy and modified radical mastoidectomy. These are open-cavity procedures. The posterior portion of the external auditory canal is sacrificed. A common cavity (mastoid bowl) is created between the ear canal and mastoid and, often, the middle ear. Regular otolaryngology follow-up for cleaning of squamous debris from the mastoid bowl is required, usually for life  (
         <a class="graphic graphic_picture graphicRef52515" href="/z/d/graphic/52515.html" rel="external">
          picture 18
         </a>
         ). Canal wall-down surgery usually includes enlargement of the soft tissue opening of the ear canal (meatoplasty) to facilitate cleaning. Cleaning of the mastoid bowl may be uncomfortable for young children. Older children and adults sometimes complain of discomfort and dizziness, even when the bowl is cleaned skillfully.
        </p>
        <p>
        </p>
        <p>
         The canal wall-up approach is usually preferred when feasible [
         <a href="#rid63">
          63
         </a>
         ]. On the other hand, canal wall-down surgery is a time-tested, safe alternative for children with large cholesteatomas or destruction of the ear canal, those who fail canal wall-up surgery, or those for whom regular follow-up cannot be assured. Without regular cleaning, a foul-smelling mastoid bowl may result as accumulated squamous debris becomes secondarily infected.
        </p>
        <p class="headingAnchor" id="H2850904264">
         <span class="h2">
          Surgical complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to the general risks of surgery (eg, bleeding, infection), the risks of ear surgery include hearing loss, facial nerve paralysis, cerebrospinal fluid leak, and TM perforation [
         <a href="#rid9">
          9,29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          OUTCOME
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recurrence
         </strong>
         – Recurrence is uncommon in children with small, encapsulated congenital cholesteatomas that are removed intact [
         <a href="#rid9">
          9,29,64
         </a>
         ]. In other patients, the risk of recurrence ranges from approximately 10 to 60 percent, depending upon the extent of disease (ie, larger more extensive cholesteatomas have a higher recurrence risk) [
         <a href="#rid6">
          6,29,50,65,66
         </a>
         ]. Lesions associated with ossicular or mastoid involvement are at particularly high risk of recurrence (up to 40 to 60 percent) [
         <a href="#rid6">
          6
         </a>
         ]. Multiple recurrences are not uncommon is such patients and they may require multiple surgeries [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other risk factors for recurrence include age &lt;8 years at diagnosis, higher initial stage of disease, and poor Eustachian tube function [
         <a href="#rid50">
          50,66,68-70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The high risk of recurrence highlights the need for regular postoperative follow-up, as described below. (See
         <a class="local">
          'Follow-up'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hearing
         </strong>
         – Hearing is usually stable or improved if the stapes superstructure is spared [
         <a href="#rid6">
          6,61,71
         </a>
         ]. Factors related to satisfactory hearing outcome include less ossicular damage and better preoperative hearing [
         <a href="#rid61">
          61,72,73
         </a>
         ]. In one series of 349 patients, most of whom underwent canal wall-down mastoidectomy, hearing improved in 30 percent (mean gain 5 decibels), remained unchanged in 55 percent, and worsened in 15 percent at a mean follow-up of 7.3 years; 30 percent of ears had a hearing threshold of 30 decibels or better [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cranial nerve palsies
         </strong>
         – Among patients who present with cranial nerve palsies, outcome is related to timeliness of diagnosis [
         <a href="#rid74">
          74
         </a>
         ]. Recovery of function is possible with early intervention.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children who have undergone treatment for cholesteatoma require regular follow-up postoperatively to prevent and control recurrent disease [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
         Children treated with excision and grafting require careful monitoring for at least two years after surgery. Even tiny fragments of cholesteatoma matrix can grow into a cholesteatoma (residual cholesteatoma) [
         <a href="#rid68">
          68
         </a>
         ]. In addition, the same forces that caused the first cholesteatoma to form can cause the grafted tympanic membrane (TM) to collapse, predisposing to the development of recurrent cholesteatoma [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
         Clinical manifestations of residual/recurrent cholesteatoma include chronic otorrhea and/or perforation of the TM [
         <a href="#rid72">
          72
         </a>
         ]. (See
         <a class="local">
          'Presentation'
         </a>
         above.)
        </p>
        <p>
         Follow-up evaluation includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Careful visualization of the ear under the operating microscope
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Annual audiograms
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Imaging, if recurrence is suspected
        </p>
        <p>
        </p>
        <p>
         In addition, children who are treated with canal wall-down surgery require regular follow-up for cleaning of squamous debris from the mastoid bowl. (See
         <a class="local">
          'Mastoid involvement'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1201439388">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109085.html" rel="external">
          "Society guideline links: Acute otitis media, otitis media with effusion, and external otitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition and predisposing factors
         </strong>
         – Cholesteatomas are abnormal accumulations of squamous epithelium within the middle ear and mastoid. They can be acquired or congenital. Predisposing factors for acquired cholesteatoma include recurrent acute otitis media and/or chronic middle ear effusions, family history of chronic middle ear disease and/or cholesteatoma, certain syndromes (eg, Down syndrome, Turner syndrome), and congenital anomalies (eg, cleft palate, craniofacial anomalies). (See
         <a class="local">
          'Terminology'
         </a>
         above and
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Presentation
         </strong>
         – Chronic ear drainage is the most common presenting symptom for acquired cholesteatomas. Most affected children have a history of recurrent acute otitis media and/or chronic middle ear effusions. Cholesteatomas also may come to attention based upon abnormal otoscopic findings on routine physical examination or abnormal routine hearing screening. Rarely, children with cholesteatoma present with a late complication (eg, facial nerve palsy). (See
         <a class="local">
          'Presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Otoscopic findings
         </strong>
         – Characteristic otoscopic findings of cholesteatoma include (see
         <a class="local">
          'Otoscopic findings'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A white mass behind an intact tympanic membrane (TM)  (
         <a class="graphic graphic_picture graphicRef72870" href="/z/d/graphic/72870.html" rel="external">
          picture 1A
         </a>
         and
         <a class="graphic graphic_picture graphicRef59937" href="/z/d/graphic/59937.html" rel="external">
          picture 1B
         </a>
         and
         <a class="graphic graphic_picture graphicRef76079" href="/z/d/graphic/76079.html" rel="external">
          picture 1C
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A deep retraction pocket  (
         <a class="graphic graphic_picture graphicRef54514" href="/z/d/graphic/54514.html" rel="external">
          picture 5
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Focal granulation on the surface of the TM especially at the periphery  (
         <a class="graphic graphic_picture graphicRef72182" href="/z/d/graphic/72182.html" rel="external">
          picture 6
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications
         </strong>
         – If not surgically excised, cholesteatomas will continue to enlarge and can cause complications including hearing loss, cranial nerve palsies, vertigo, and serious infections (eg, meningitis, brain abscess). Early detection, which requires careful otoscopic examination at routine health maintenance visits, is important to reduce the risk of these complications. (See
         <a class="local">
          'Clinical features'
         </a>
         above and
         <a class="local">
          'Clinical suspicion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of cholesteatoma is confirmed by the otolaryngologist using visual examination and palpation under an operating microscope, high-resolution computed tomography of the temporal bone, diffusion-weighted magnetic resonance imaging, and/or surgical exploration. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis of cholesteatoma includes other white lesions of the TM:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Myringosclerosis  (
         <a class="graphic graphic_picture graphicRef58460" href="/z/d/graphic/58460.html" rel="external">
          picture 11
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Foreign body  (
         <a class="graphic graphic_picture graphicRef73085" href="/z/d/graphic/73085.html" rel="external">
          picture 12
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Exostoses (outgrowths of bone into the external ear canal)  (
         <a class="graphic graphic_picture graphicRef53371" href="/z/d/graphic/53371.html" rel="external">
          picture 13
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prosthetic and graft material in operated ears
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inclusion cysts of TM  (
         <a class="graphic graphic_picture graphicRef54229" href="/z/d/graphic/54229.html" rel="external">
          picture 14
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Occasionally, a bulging acute otitis media may be hard to differentiate from a large congenital cholesteatoma  (
         <a class="graphic graphic_picture graphicRef76431" href="/z/d/graphic/76431.html" rel="external">
          picture 15
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Cholesteatomas are treated surgically. The goals of surgery are eradication of the keratinizing squamous epithelium from the temporal bone and preservation or restoration of hearing. The extent of surgery depends upon the size and stage of the cholesteatoma. (See
         <a class="local">
          'Surgical treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recurrence risk
         </strong>
         – Recurrence is uncommon in children with small congenital cholesteatomas that are successfully removed. In other patients, the risk of recurrence ranges from approximately 10 to 60 percent, depending upon the extent of disease. Lesions associated with ossicular or mastoid involvement are at particularly high risk of recurrence. Signs of recurrence include chronic drainage and/or perforation of the TM. (See
         <a class="local">
          'Outcome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Follow-up
         </strong>
         – Children require regular follow-up postoperatively to monitor for complications and to prevent and control recurrent disease. Follow-up includes annual audiograms, careful visualization of the ear under the operating microscope, and imaging if recurrence is suspected. (See
         <a class="local">
          'Follow-up'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Isaacson G. Diagnosis of pediatric cholesteatoma. Pediatrics 2007; 120:603.
          </a>
         </li>
         <li class="breakAll">
          Bluestone CD, Klein JO. Intratemporal complications and sequelae of otitis media. In: Pediatric otolaryngology, 4th ed, Bluestone CD, Casselbrant ML, Stool SE, et al (Eds), Saunders, Philadelphia 2003. p.687.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Derlacki EL, Clemis JD. Congenital cholesteatoma of the middle ear and mastoid. Ann Otol Rhinol Laryngol 1965; 74:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu JH, Rutter MJ, Choo DI, Willging JP. Congenital cholesteatoma of the middle ear. Clin Pediatr (Phila) 2000; 39:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levenson MJ, Parisier SC, Chute P, et al. A review of twenty congenital cholesteatomas of the middle ear in children. Otolaryngol Head Neck Surg 1986; 94:560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Potsic WP, Korman SB, Samadi DS, Wetmore RF. Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia. Otolaryngol Head Neck Surg 2002; 126:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol 1999; 119:568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin V, Daniel S, James A, Friedberg J. Bilateral cholesteatomas: the hospital for sick children experience. J Otolaryngol 2004; 33:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennett M, Warren F, Jackson GC, Kaylie D. Congenital cholesteatoma: theories, facts, and 53 patients. Otolaryngol Clin North Am 2006; 39:1081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spilsbury K, Miller I, Semmens JB, Lannigan FJ. Factors associated with developing cholesteatoma: a study of 45,980 children with middle ear disease. Laryngoscope 2010; 120:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheahan P, Blayney AW, Sheahan JN, Earley MJ. Sequelae of otitis media with effusion among children with cleft lip and/or cleft palate. Clin Otolaryngol Allied Sci 2002; 27:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dominguez S, Harker LA. Incidence of cholesteatoma with cleft palate. Ann Otol Rhinol Laryngol 1988; 97:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Djurhuus BD, Skytthe A, Faber CE, Christensen K. Cholesteatoma risk in 8,593 orofacial cleft cases and 6,989 siblings: A nationwide study. Laryngoscope 2015; 125:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dhooge IJ, De Vel E, Verhoye C, et al. Otologic disease in turner syndrome. Otol Neurotol 2005; 26:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacciu A, Pasanisi E, Vincenti V, et al. Surgical treatment of middle ear cholesteatoma in children with Down syndrome. Otol Neurotol 2005; 26:1007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prinsley P. Familial cholesteatoma in East Anglia, UK. J Laryngol Otol 2009; 123:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Homøe P, Rosborg J. Family cluster of cholesteatoma. J Laryngol Otol 2007; 121:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collins R, Ta NH, Jennings BA, et al. Cholesteatoma and family history: An international survey. Clin Otolaryngol 2020; 45:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Semaan MT, Megerian CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am 2006; 39:1143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persaud R, Hajioff D, Trinidade A, et al. Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma. J Laryngol Otol 2007; 121:1013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liang J, Michaels L, Wright A. Immunohistochemical characterization of the epidermoid formation in the middle ear. Laryngoscope 2003; 113:1007.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kayhan FT, Mutlu C, Schachern PA, et al. Significance of epidermoid formations in the middle ear in fetuses and children. Arch Otolaryngol Head Neck Surg 1997; 123:1293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller DT, Schwetschenau EL, Isaacson G. Occult contralateral congenital cholesteatoma: is the epidermoid formation theory enough? Am J Otolaryngol 2004; 25:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eavey RD, Camacho A, Northrop CC. Chronic ear pathology in a model of neonatal amniotic fluid ear inoculation. Arch Otolaryngol Head Neck Surg 1992; 118:1198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tos M. A new pathogenesis of mesotympanic (congenital) cholesteatoma. Laryngoscope 2000; 110:1890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lau T, Tos M. Tensa retraction cholesteatoma: treatment and long-term results. J Laryngol Otol 1989; 103:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paço J, Branco C, Estibeiro H, Oliveira E Carmo D. The posterosuperior quadrant of the tympanic membrane. Otolaryngol Head Neck Surg 2009; 140:884.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Semple CW, Mahadevan M, Berkowitz RG. Extensive acquired cholesteatoma in children: when the penny drops. Ann Otol Rhinol Laryngol 2005; 114:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sie KC. Cholesteatoma in children. Pediatr Clin North Am 1996; 43:1245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koltai PJ, Nelson M, Castellon RJ, et al. The natural history of congenital cholesteatoma. Arch Otolaryngol Head Neck Surg 2002; 128:804.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levenson MJ, Michaels L, Parisier SC. Congenital cholesteatomas of the middle ear in children: origin and management. Otolaryngol Clin North Am 1989; 22:941.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGill TJ, Merchant S, Healy GB, Friedman EM. Congenital cholesteatoma of the middle ear in children: a clinical and histopathological report. Laryngoscope 1991; 101:606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palacios E, Valvassori G. Congenital cholesteatoma of the middle ear. Ear Nose Throat J 1998; 77:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg JS, Manolidis S. High incidence of complications encountered in chronic otitis media surgery in a U.S. metropolitan public hospital. Otolaryngol Head Neck Surg 2001; 125:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prescott CA. Cholesteatoma in children--the experience at The Red Cross War Memorial Children's Hospital in South Africa 1988-1996. Int J Pediatr Otorhinolaryngol 1999; 49:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matanda RN, Muyunga KC, Sabue MJ, et al. Chronic suppurative otitis media and related complications at the University Clinic of Kinshasa. B-ENT 2005; 1:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mustafa A, Heta A, Kastrati B, Dreshaj Sh. Complications of chronic otitis media with cholesteatoma during a 10-year period in Kosovo. Eur Arch Otorhinolaryngol 2008; 265:1477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maksimović Z, Rukovanjski M. Intracranial complications of cholesteatoma. Acta Otorhinolaryngol Belg 1993; 47:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith JA, Danner CJ. Complications of chronic otitis media and cholesteatoma. Otolaryngol Clin North Am 2006; 39:1237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grundfast KM, Ahuja GS, Parisier SC, Culver SM. Delayed diagnosis and fate of congenital cholesteatoma (keratoma). Arch Otolaryngol Head Neck Surg 1995; 121:903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Migirov L, Yakirevitch A, Kronenberg J. Mastoid subperiosteal abscess: a review of 51 cases. Int J Pediatr Otorhinolaryngol 2005; 69:1529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manolidis S, Kutz JW Jr. Diagnosis and management of lateral sinus thrombosis. Otol Neurotol 2005; 26:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz RH, Grundfast KM, Feldman B, et al. Cholesteatoma medial to an intact tympanic membrane in 34 young children. Pediatrics 1984; 74:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Foer B, Vercruysse JP, Bernaerts A, et al. Middle ear cholesteatoma: non-echo-planar diffusion-weighted MR imaging versus delayed gadolinium-enhanced T1-weighted MR imaging--value in detection. Radiology 2010; 255:866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plouin-Gaudon I, Bossard D, Ayari-Khalfallah S, Froehlich P. Fusion of MRIs and CT scans for surgical treatment of cholesteatoma of the middle ear in children. Arch Otolaryngol Head Neck Surg 2010; 136:878.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Kalle T, Amrhein P, Koitschev A. Non-echoplanar diffusion-weighted MRI in children and adolescents with cholesteatoma: reliability and pitfalls in comparison to middle ear surgery. Pediatr Radiol 2015; 45:1031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller DT, Isaacson G. Staged tympanostomy tube placement facilitates pediatric cholesteatoma management. Int J Pediatr Otorhinolaryngol 2008; 72:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castle JT. Cholesteatoma Pearls: Practical Points and Update. Head Neck Pathol 2018; 12:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luu K, Chi D, Kiyosaki KK, Chang KW. Updates in Pediatric Cholesteatoma: Minimizing Intervention While Maximizing Outcomes. Otolaryngol Clin North Am 2019; 52:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenfeld RM, Moura RL, Bluestone CD. Predictors of residual-recurrent cholesteatoma in children. Arch Otolaryngol Head Neck Surg 1992; 118:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shirazi MA, Muzaffar K, Leonetti JP, Marzo S. Surgical treatment of pediatric cholesteatomas. Laryngoscope 2006; 116:1603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCabe R, Lee DJ, Fina M. The Endoscopic Management of Congenital Cholesteatoma. Otolaryngol Clin North Am 2021; 54:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jenks CM, Purcell PL, Federici G, et al. Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma: A Multi-institutional Series. Otolaryngol Head Neck Surg 2022; 167:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James AL, Cushing S, Papsin BC. Residual Cholesteatoma After Endoscope-guided Surgery in Children. Otol Neurotol 2016; 37:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grimes ER, Isaacson G. The mechanical reduction of early acquired cholesteatomas in children: indications and limitations. Ear Nose Throat J 2006; 85:252, 254, 256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bluestone CD, Cantekin EI, Beery QC, Stool SE. Function of the Eustachian tube related to surgical management of acquired aural cholesteatoma in children. Laryngoscope 1978; 88:1155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blaney SP, Tierney P, Bowdler DA. The surgical management of the pars tensa retraction pocket in the child--results following simple excision and ventilation tube insertion. Int J Pediatr Otorhinolaryngol 1999; 50:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarcu D, Isaacson G. Long-term Results of Endoscopically Assisted Pediatric Cholesteatoma Surgery. Otolaryngol Head Neck Surg 2016; 154:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghadersohi S, Carter JM, Hoff SR. Endoscopic transcanal approach to the middle ear for management of pediatric cholesteatoma. Laryngoscope 2017; 127:2653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen MS, Basonbul RA, Kozin ED, Lee DJ. Residual Cholesteatoma during Second-Look Procedures following Primary Pediatric Endoscopic Ear Surgery. Otolaryngol Head Neck Surg 2017; 157:1034.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin VY, Campisi P, Friedberg J. Why do some children have good hearing results following type III and IV tympanoplasty? Current theories of middle ear mechanics. J Otolaryngol 2006; 35:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           East DM. Atticotomy with reconstruction for limited cholesteatoma. Clin Otolaryngol Allied Sci 1998; 23:248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osborn AJ, Papsin BC, James AL. Clinical indications for canal wall-down mastoidectomy in a pediatric population. Otolaryngol Head Neck Surg 2012; 147:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lazard DS, Roger G, Denoyelle F, et al. Congenital cholesteatoma: risk factors for residual disease and retraction pockets--a report on 117 cases. Laryngoscope 2007; 117:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stapleton AL, Egloff AM, Yellon RF. Congenital cholesteatoma: predictors for residual disease and hearing outcomes. Arch Otolaryngol Head Neck Surg 2012; 138:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stangerup SE, Drozdziewicz D, Tos M, Trabalzini F. Surgery for acquired cholesteatoma in children: long-term results and recurrence of cholesteatoma. J Laryngol Otol 1998; 112:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hermann R, Blanc J, Fieux M, et al. Multi-operated cholesteatoma: when two surgeries are not enough. Eur Arch Otorhinolaryngol 2021; 278:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stangerup SE, Drozdziewicz D, Tos M. Cholesteatoma in children, predictors and calculation of recurrence rates. Int J Pediatr Otorhinolaryngol 1999; 49 Suppl 1:S69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maassen MM, Plinkert PK, Diedrichs H, et al. [Functional long-term results after open cholesteatoma surgery and ossiculoplasty with allogenic ossicles in adulthood]. Laryngorhinootologie 1998; 77:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McRackan TR, Abdellatif WM, Wanna GB, et al. Evaluation of second look procedures for pediatric cholesteatomas. Otolaryngol Head Neck Surg 2011; 145:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolter NE, Holler T, Cushing SL, et al. Pediatric ossiculoplasty with titanium total ossicular replacement prosthesis. Laryngoscope 2015; 125:740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vartiainen E, Vartiainen J. Hearing results of surgery for acquired cholesteatoma. Ear Nose Throat J 1995; 74:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chadha NK, Jardine A, Owens D, et al. A multivariate analysis of the factors predicting hearing outcome after surgery for cholesteatoma in children. J Laryngol Otol 2006; 120:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siddiq MA, Hanu-Cernat LM, Irving RM. Facial palsy secondary to cholesteatoma: analysis of outcome following surgery. J Laryngol Otol 2007; 121:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roger G, Denoyelle F, Chauvin P, et al. Predictive risk factors of residual cholesteatoma in children: a study of 256 cases. Am J Otol 1997; 18:550.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6306 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766534" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Diagnosis of pediatric cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766534" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Diagnosis of pediatric cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5846535" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Congenital cholesteatoma of the middle ear and mastoid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11005370" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Congenital cholesteatoma of the middle ear.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3088516" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : A review of twenty congenital cholesteatomas of the middle ear in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11997782" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10478597" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Epidemiology and aetiology of middle ear cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15841990" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Bilateral cholesteatomas: the hospital for sick children experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17097434" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Congenital cholesteatoma: theories, facts, and 53 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20058316" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Factors associated with developing cholesteatoma: a study of 45,980 children with middle ear disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12472518" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Sequelae of otitis media with effusion among children with cleft lip and/or cleft palate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3202568" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Incidence of cholesteatoma with cleft palate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25388367" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Cholesteatoma risk in 8,593 orofacial cleft cases and 6,989 siblings: A nationwide study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15793396" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Otologic disease in turner syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16151350" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Surgical treatment of middle ear cholesteatoma in children with Down syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18492311" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Familial cholesteatoma in East Anglia, UK.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17059626" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Family cluster of cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32271986" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Cholesteatoma and family history: An international survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17097438" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The pathophysiology of cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17697435" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12782813" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Immunohistochemical characterization of the epidermoid formation in the middle ear.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9413356" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Significance of epidermoid formations in the middle ear in fetuses and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15239040" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Occult contralateral congenital cholesteatoma: is the epidermoid formation theory enough?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1384561" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Chronic ear pathology in a model of neonatal amniotic fluid ear inoculation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11081605" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : A new pathogenesis of mesotympanic (congenital) cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2926259" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Tensa retraction cholesteatoma: treatment and long-term results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19467409" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The posterosuperior quadrant of the tympanic membrane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16134350" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Extensive acquired cholesteatoma in children: when the penny drops.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8973511" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Cholesteatoma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12117340" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The natural history of congenital cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2694070" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Congenital cholesteatomas of the middle ear in children: origin and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2041440" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Congenital cholesteatoma of the middle ear in children: a clinical and histopathological report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9745175" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Congenital cholesteatoma of the middle ear.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11743464" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : High incidence of complications encountered in chronic otitis media surgery in a U.S. metropolitan public hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10428401" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Cholesteatoma in children--the experience at The Red Cross War Memorial Children's Hospital in South Africa 1988-1996.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16044735" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Chronic suppurative otitis media and related complications at the University Clinic of Kinshasa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18478242" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Complications of chronic otitis media with cholesteatoma during a 10-year period in Kosovo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8470548" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Intracranial complications of cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17097444" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Complications of chronic otitis media and cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7619419" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Delayed diagnosis and fate of congenital cholesteatoma (keratoma).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15908017" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Mastoid subperiosteal abscess: a review of 51 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16151357" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Diagnosis and management of lateral sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6540436" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Cholesteatoma medial to an intact tympanic membrane in 34 young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20501723" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Middle ear cholesteatoma: non-echo-planar diffusion-weighted MR imaging versus delayed gadolinium-enhanced T1-weighted MR imaging--value in detection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20855680" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Fusion of MRIs and CT scans for surgical treatment of cholesteatoma of the middle ear in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25676040" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Non-echoplanar diffusion-weighted MRI in children and adolescents with cholesteatoma: reliability and pitfalls in comparison to middle ear surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18023884" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Staged tympanostomy tube placement facilitates pediatric cholesteatoma management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30069838" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Cholesteatoma Pearls: Practical Points and Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31280890" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Updates in Pediatric Cholesteatoma: Minimizing Intervention While Maximizing Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1554467" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Predictors of residual-recurrent cholesteatoma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16954988" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Surgical treatment of pediatric cholesteatomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33153732" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The Endoscopic Management of Congenital Cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34932403" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma: A Multi-institutional Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26719964" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Residual Cholesteatoma After Endoscope-guided Surgery in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16696360" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The mechanical reduction of early acquired cholesteatomas in children: indications and limitations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/672348" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Function of the Eustachian tube related to surgical management of acquired aural cholesteatoma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10576614" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The surgical management of the pars tensa retraction pocket in the child--results following simple excision and ventilation tube insertion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26721891" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Long-term Results of Endoscopically Assisted Pediatric Cholesteatoma Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28543174" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Endoscopic transcanal approach to the middle ear for management of pediatric cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28871887" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Residual Cholesteatoma during Second-Look Procedures following Primary Pediatric Endoscopic Ear Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17176796" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Why do some children have good hearing results following type III and IV tympanoplasty? Current theories of middle ear mechanics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9669075" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Atticotomy with reconstruction for limited cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22565050" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Clinical indications for canal wall-down mastoidectomy in a pediatric population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17415133" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Congenital cholesteatoma: risk factors for residual disease and retraction pockets--a report on 117 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22431873" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Congenital cholesteatoma: predictors for residual disease and hearing outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9850315" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Surgery for acquired cholesteatoma in children: long-term results and recurrence of cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32535859" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Multi-operated cholesteatoma: when two surgeries are not enough.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10577779" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Cholesteatoma in children, predictors and calculation of recurrence rates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9555699" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : [Functional long-term results after open cholesteatoma surgery and ossiculoplasty with allogenic ossicles in adulthood].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21493359" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Evaluation of second look procedures for pediatric cholesteatomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25154744" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Pediatric ossiculoplasty with titanium total ossicular replacement prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7729339" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Hearing results of surgery for acquired cholesteatoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17040585" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : A multivariate analysis of the factors predicting hearing outcome after surgery for cholesteatoma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17078895" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Facial palsy secondary to cholesteatoma: analysis of outcome following surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9303150" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Predictive risk factors of residual cholesteatoma in children: a study of 256 cases.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
